47264 Federal Register / Vol. 74, No. 177 / Tuesday, September 15, 2009 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3180, 

MSC 7848, Bethesda, MD 20892, (301) 435– 

1261, wiggsc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; NMB 

Revisions. 

Date: October 1, 2009. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, NW., Washington, DC 

20037. 

Contact Person: Edwin C. Clayton, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5095C, 

MSC 7844, Bethesda, MD 20892, (301) 402– 

1304, claytone@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Biostatistical Methods 

and Research Design Study Section. 

Date: October 2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Amalfi Hotel, 20 West Kinzie Street, 

Chicago, IL 60654. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

0684, wieschd@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Social Psychology, Personality and 

Interpersonal Processes Study Section. 

Date: October 2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Michael Micklin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3136, 

MSC 7759, Bethesda, MD 20892, (301) 435– 

1258, micklinm@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Intercellular 

Interactions Study Section. 

Date: October 2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Legacy Hotel, 1775 Rockville Pike, 

Rockville, MD 20852. 

Contact Person: David Balasundaram, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5189, 

MSC 7840, Bethesda, MD 20892, 301–435– 

1022, balasundaramd@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Competitive 

Revisions; Clinical Neuroscience and 

Disease. 

Date: October 2, 2009. 

Time: 10 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel at the Chevy 

Chase Pavilion, 4300 Military Road, 

Washington, DC 20015. 

Contact Person: Seetha Bhagavan, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1126, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1121, bhagavas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Pregnancy 

and Neonatology/PN ARRA CR. 

Date: October 2, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: InterContinental Harbor Court 

Baltimore, 550 Light Street, Baltimore, MD 

21202. 

Contact Person: Michael Knecht, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6176, 

MSC 7892, Bethesda, MD 20892, (301) 435– 

1046, knechtm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 2, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–22011 Filed 9–14–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel T32 SEP 

Review. 

Date: October 5, 2009. 

Time: 5 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Robert Bird, PhD, Chief, 

Resources and Training Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, 6116 Executive Boulevard, 

Room 8113, Bethesda, MD 20892–8328, 301– 

496–7978, birdr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI 

Discovery and Development. 

Date: October 6–7, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC/Rockville, 

Hotel & Executive Meeting Center, 1750 

Rockville Pike, Hollow Square, Rockville, 

MD. 

Contact Person: Peter J. Wirth, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 6116 

Executive Boulevard, Room 8131, Bethesda, 

MD 20892–8328, 301–496–7565, 

pw2q@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Innovative 

Technology Development for Cancer 

Research (R21). 

Date: October 14, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5701 Marinelli 

Road, Bethesda, MD 20852. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8059, 

Bethesda, MD 20892–8329, 301–496–7904, 

decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Clinical 

Studies. 

Date: October 14–15, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Majed M. Hamawy, 

M.B.A., PhD, Scientific Review Officer, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8135, Bethesda, MD 20852, 301–594– 

5659, mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Molecular 

Oncology—Basic, Translational and Clinical 

Studies. 

Date: October 19–20, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC/Rockville, 

Executive Meeting Center, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Michael B. Small, PhD, 

Scientific Review Officer, Division of 


sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 74, No. 177 / Tuesday, September 15, 2009 / Notices 47265 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8127, Bethesda, MD 

20892–8328, 301–402–0996, 

smallm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–22014 Filed 9–14–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel; Small 

Research Grants Review. 

Date: September 23, 2009. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Michael L. Bloom, PhD, 

MBA, Scientific Review Officer, National 

Institute of Arthritis, Musculoskeletal and 

Skin Diseases, National Institutes of Health, 

6701 Democracy Blvd; Room 820, MSC 4872, 

Bethesda, MD 20892–4872, 301–594–4953, 

Michael_Bloom@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: September 9. 2009. 

Jennifer Spaeth. 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–22227 Filed 9–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

September 11, 2009, 11 a.m. to 

September 11, 2009, 12 p.m., National 

Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, which was 

published in the Federal Register on 

August 31, 2009, 74 FR 44859. 

The meeting will be held September 

14, 2009, from 1:30 p.m. to 3 p.m. The 

meeting location remains the same. The 

meeting is closed to the public. 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–22015 Filed 9–14–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

H—Clinical Groups 

Date: October 5–6, 2009. 

Time: 8 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Timothy C. Meeker, MD, 

PhD, Scientific Review Officer, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8103, Bethesda, MD 20892, (301) 594–1279, 

meekert@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 3, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–22017 Filed 9–14–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cellular 

and Tissue Oncology. 

Date: October 6–7, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Shakeel Ahmad, PhD, 

Scientific Review Officer, Research Programs 


sroberts on DSKD5P82C1PROD with NOTICES